Clinical Trial
Randomized steroid therapy of human kidney transplant rejection
Affiliations
- PMID: 401194
Item in Clipboard
Clinical Trial
Randomized steroid therapy of human kidney transplant rejection
Surg Forum.
1978.
Abstract
This randomized, double-blind study failed to show any therapeutic benefit of a 30-mg/kg bolus over a 3-mg/kg bolus of methylprednisolone for the treatment of acute kidney transplant rejection. Since there was a slight associated increase in infections and septic mortality, routine use of high-dose methylprednisolone bolus therapy is not recommended or justified.
Similar articles
-
Randomized steroid therapy of human kidney transplant rejection.Transplant Proc. 1979 Mar;11(1):36-8. Transplant Proc. 1979. PMID: 377656 Clinical Trial. No abstract available.
-
Intravenous methylprednisolone at the time of renal transplantation.Proc Eur Dial Transplant Assoc. 1983;19:482-7. Proc Eur Dial Transplant Assoc. 1983. PMID: 6348749
-
High dose (bolus) intravenous methylprednisolone at the time of kidney homotransplantation.Ann Surg. 1977 Nov;186(5):631-4. doi: 10.1097/00000658-197711000-00015. Ann Surg. 1977. PMID: 335989 Free PMC article. Clinical Trial.
-
Impact of methylprednisolone on first renal allograft rejection.Transplant Proc. 1981 Mar;13(1 Pt 1):328-31. Transplant Proc. 1981. PMID: 7022846 Clinical Trial. No abstract available.
-
Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.Transplant Proc. 1989 Feb;21(1 Pt 2):1755-7. Transplant Proc. 1989. PMID: 2652574 Clinical Trial. No abstract available.